Skip to content

    AVITA Medical (RCEL) stock price & financials

    View RCEL earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+128.5% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $19.55M
    $18.41M
    $18.51M
    $18.42M
    $17.06M
    -12.7%
    $17.62M
    -4.3%
    $19.25M
    +4.0%
    $21.70M
    +17.8%
    Strengthening
    Operating Profit
    -$13.81M
    -$9.96M
    -$11.83M
    -$11.15M
    -$9.15M
    +33.7%
    -$10.41M
    -4.5%
    -$8.80M
    +25.6%
    -$6.86M
    +38.5%
    Strengthening
    Net Profit
    -$16.20M
    -$11.59M
    -$13.86M
    -$9.92M
    -$13.19M
    +18.6%
    -$11.62M
    -0.3%
    -$10.61M
    +23.4%
    -$7.66M
    +22.8%
    Strengthening
    EPS
    $-0.62
    $-0.53
    $-0.38
    $-0.46
    +25.8%
    $-0.35
    +34.0%
    $-0.25
    +34.2%
    Strengthening
    Other Income
    Interest
    $1.36M
    $1.30M
    $1.23M
    $1.25M
    $1.27M
    -6.7%
    $1.25M
    -3.7%
    $1.42M
    +15.5%
    $1.46M
    +16.9%
    Strengthening
    Depreciation
    Profit before Tax
    -$16.23M
    -$11.57M
    -$13.85M
    -$9.92M
    -$13.17M
    +18.9%
    -$11.64M
    -0.6%
    -$10.62M
    +23.3%
    -$7.63M
    +23.1%
    Strengthening
    MarginsOPM
    -70.6%
    -54.1%
    -63.9%
    -60.5%
    -53.6%
    +24.0%
    -59.1%
    -9.2%
    -45.7%
    +28.4%
    -31.6%
    +47.8%
    Strengthening
    Tax
    0.2%
    -0.2%
    -0.1%
    -0.0%
    -0.1%
    -164.7%
    0.1%
    0.1%
    -0.4%
    -975.0%
    Weakening
    ReturnsROIC
    3.8%
    2.7%
    3.2%
    2.3%
    3.1%
    -18.6%
    2.7%
    +0.3%
    2.5%
    -23.4%
    1.8%
    -22.8%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$10.99M$20.17M$73.64M$110.75M$18.16M$22.12M$14.05M$10.24M$9.14M
    Short-Term Investments$61.18M$66.94M$21.84M$7.94M$2.00M
    Total Current Assets$24.13M$78.39M$121.33M$87.46M$104.01M$57.00M$35.49M$28.39M
    Net PP&E$1.31M$3.71M$2.94M$2.05M$4.32M$13.59M$11.53M$10.33M
    Goodwill
    Intangibles$225.0K$364.0K$472.0K$465.0K$487.0K$5.57M$5.64M$5.25M
    Total Assets$25.78M$82.46M$125.50M$98.26M$111.64M$79.71M$56.39M$47.78M
    LiabilitiesTotal Current Liabilities$4.48M$7.71M$7.39M$10.69M$13.20M$20.16M$62.68M$68.71M
    Short-Term Debt$0$42.98M$46.66M
    Long-Term Debt$39.81M$42.24M$0
    Long-Term Leases$1.92M$878.0K$306.0K$1.70M$2.84M$2.13M$1.82M
    Total Liabilities$4.95M$10.06M$9.85M$12.97M$61.89M$74.97M$73.04M$75.61M
    EquityCommon Stock & APIC$3.0K$3.0K$3.0K$3.0K$3.0K$3.0K$3.0K$3.0K
    Retained Earnings-$152.83M-$194.91M-$221.50M-$262.59M-$297.97M-$359.81M-$408.40M-$426.68M
    Total Equity$14.03M$20.83M$72.40M$115.66M$84.74M$49.06M$4.50M-$16.65M-$27.84M
    HighlightsNet Cash / (Debt)-$6.36M-$24.80M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$12.96M-$19.25M-$22.75M-$25.90M-$19.09M-$38.01M-$48.90M-$31.20M-$24.23M
    Cash from Investing-$365.0K-$1.23M-$847.0K-$1.17M-$19.33M$1.61M$37.36M$12.45M$600.0K
    Cash from Financing$21.30M$29.71M$77.06M$64.05M$900.0K$40.37M$3.51M$14.94M$20.55M
    SummaryCapital Expenditure-$365.0K-$1.02M-$590.0K-$894.0K-$452.0K-$1.38M-$9.17M-$1.00M-$387.0K
    Free Cash Flow-$13.32M-$20.27M-$23.34M-$26.80M-$19.54M-$39.39M-$58.07M-$32.20M-$24.62M
    FCF Margin-1434.3%-370.3%-163.6%-91.7%-56.8%-78.6%-90.4%-45.0%-32.5%

    Ratios